Aslanger Pattern – ECG
Appcardio ECG Library · Ischaemia and acute coronary occlusion
ECG - Aslanger Pattern
A subtle electrocardiographic pattern that may reveal acute inferior myocardial infarction in the setting of concomitant multivessel coronary disease—even when conventional contiguous inferior ST-elevation criteria are not met.
1. Introduction
The Aslanger pattern is a specific 12-lead ECG configuration associated with acute inferior myocardial infarction (MI), often with critical disease in one or more additional coronary arteries. Its importance is that the ECG may not show the contiguous ST-segment elevation conventionally required for an inferior STEMI diagnosis.
The pattern was described by Aslanger and colleagues in 2020. In their retrospective cohort, it was identified in 6.3% of patients classified as non-STEMI and 0.5% of patients without MI. The authors reported larger infarct size and a higher frequency of angiographic culprit lesions and acute coronary occlusion than in the comparator NSTEMI group. The pattern should therefore prompt clinicians to consider an acute coronary occlusion rather than relying on the STEMI/NSTEMI label alone.
These are findings from the original retrospective study, not population-wide prevalence estimates or validated diagnostic-performance values.
2. Electrophysiology and Pathophysiology
The proposed explanation is the superposition of two ST-segment injury/ischemia vectors:
- Inferior-wall injury current: a relatively localized inferior injury vector may be directed inferiorly and rightward, contributing to ST elevation in lead III.
- Concomitant subendocardial ischaemia: more diffuse subendocardial ischaemia, often related to critical disease in non-culprit coronary territories, produces a widespread ST vector directed toward aVR (and away from many left-sided leads), contributing to lateral precordial ST depression.
The net ST vector can therefore produce an apparently discordant pattern: isolated inferior ST elevation in III, lateral precordial ST depression, and a higher ST level in V1 than V2. The vector model is a proposed explanatory framework, not a direct measurement of the electrical source in an individual patient.
3. Characteristic ECG Features
Assess the ST segments in the inferior and precordial leads carefully. The classic pattern is defined by three features:
| ECG component | Expected observation | Interpretive point |
|---|---|---|
| Inferior leads | ST elevation in III, not in II or aVF | Isolated rather than contiguous inferior STE |
| Leads V4–V6 | ST depression in one or more leads, with positive or terminally positive T wave | Suggests accompanying subendocardial ischaemia in the described pattern |
| Lead V2 | Not the lead showing the specified lateral-precordial ST depression | Preserve the distinction in the original definition |
| V1 compared with V2 | ST level in V1 higher than in V2 | A relative comparison, not a universal millimetre threshold |
Heart rate, rhythm, PR interval, QRS width, QT interval and axis are not defining criteria. Interpret these conventionally and document abnormalities when present, but do not use them to replace the three pattern criteria.
4. Systematic ECG Interpretation
- Confirm technical quality. Check calibration, paper speed, artefact and limb-lead placement. Compare with prior ECGs if available.
- Establish the clinical context. Ask whether symptoms are compatible with acute myocardial ischaemia, including ongoing or recurrent chest discomfort, dyspnoea, diaphoresis or haemodynamic compromise.
- Inspect inferior leads together. Look for ST elevation in III and verify that II and aVF do not show corresponding ST elevation.
- Inspect V4–V6. Look for ST depression with a positive or terminally positive T wave; confirm that the described depression is not simply a V2 finding.
- Compare V1 and V2. Compare ST levels at the same reference point and confirm that V1 is higher than V2.
- Integrate the pattern. If all three features coexist, consider an Aslanger pattern and possible acute inferior OMI with multivessel coronary disease.
- Escalate and reassess. Review serial ECGs, biomarkers, bedside imaging and the overall ACS risk; obtain urgent senior/interventional cardiology assessment when acute occlusion is suspected.
5. Diagnostic Criteria and Limitations
The original operational definition is the presence of all three ECG features below:
| Criterion | Required finding | What must be checked |
|---|---|---|
| 1 | Any ST elevation in lead III, but not in other inferior leads | No ST elevation in II or aVF |
| 2 | ST depression in any of V4–V6 (but not in V2), with positive or terminally positive T wave | Identify the lead(s), ST deviation and T-wave polarity |
| 3 | ST segment in V1 higher than in V2 | Compare relative ST levels directly |
The source definition does not provide a separate numerical ST-elevation threshold for lead III or a numerical V1–V2 difference. Do not add an unsupported millimetre cut-off when applying this specific pattern definition.
Limitations of the evidence
- The original study was retrospective and conducted at a single centre; the authors called for further evaluation.
- The pattern was also observed in a small proportion of patients without acute MI (0.5% in the original cohort), potentially reflecting chronic ischaemic changes.
- Previous infarction may alter the net injury vector and produce a similar appearance.
- Subsequent case reports and cohort studies broaden clinical experience but do not make the pattern a definitive stand-alone test for acute coronary occlusion.
6. Differential Diagnosis
| Alternative diagnosis | Potential overlap | Features that help distinguish it |
|---|---|---|
| Conventional inferior STEMI | Inferior ST elevation and reciprocal changes | Usually has contiguous ST elevation in at least two inferior leads; the classic Aslanger definition has isolated III elevation. |
| Diffuse subendocardial ischaemia | ST depression in multiple leads and possible aVR elevation | May occur with left main or multivessel disease; does not by itself establish the specific inferior lead III component or acute inferior infarction. |
| Posterior MI | Anterior precordial ST depression, sometimes with upright T waves | Consider posterior leads V7–V9 and the broader ECG/clinical picture. Posterior MI can coexist with other ischaemic patterns. |
| Chronic ischaemic or post-infarction changes | Persistent ST/T abnormalities may mimic acute patterns | Compare prior ECGs, symptoms, serial ECG evolution, biomarkers and imaging. |
| Lead misplacement or technical artefact | Can create apparent ST-level differences or unexpected lead patterns | Verify lead placement, calibration and repeat the ECG when necessary. |
These are practical differential considerations rather than a validated exclusion algorithm. The pattern must be interpreted in context and should not delay evaluation for other acute coronary occlusion patterns.
7. Clinical Significance and Prognostic Considerations
In the original study, patients with the pattern had larger infarct size (using 24-hour troponin as an indicator), more frequent angiographic culprit lesions and a higher frequency of the composite acute coronary occlusion endpoint than other NSTEMI patients. Their in-hospital and one-year mortality were reported as similar to the inferior STEMI comparison group.
\nA later small, single-centre retrospective cohort of patients with acute inferior coronary occlusion reported multivessel disease in 80% of patients with the pattern, mechanical circulatory support use in 30%, and in-hospital mortality of 20%. These figures describe that selected cohort and should not be generalized as expected rates for all patients with the pattern.
- Potential missed OMI: classification as NSTEMI based only on absence of contiguous inferior STE may delay recognition of an acute occlusion.
- Multivessel disease: concomitant critical stenoses may complicate culprit-lesion identification during angiography.
- Reperfusion priority: the pattern should raise concern for an acutely compromised inferior-wall territory; angiographic findings and clinical context determine the revascularization strategy.
8. Clinical Evaluation and Management Principles
There is no separate treatment protocol established solely by the Aslanger ECG pattern. Manage the patient as suspected acute coronary syndrome with possible acute coronary occlusion, using local ACS pathways and urgent cardiology input.
Immediate assessment
- Assess airway, breathing, circulation, perfusion and haemodynamic stability; obtain continuous rhythm monitoring in an appropriate acute-care setting.
- Clarify symptom onset, duration, recurrence, associated symptoms, cardiovascular history and contraindications to antithrombotic therapy.
- Obtain and interpret a 12-lead ECG promptly; repeat ECGs with ongoing symptoms or clinical change. Consider posterior/right-sided leads when clinically indicated.
- Measure high-sensitivity cardiac troponin using the validated local serial algorithm. A normal early value does not exclude evolving MI.
- Use focused echocardiography when it can rapidly assess regional wall-motion abnormality, LV function or alternative causes, without delaying necessary reperfusion decisions.
Escalation and invasive evaluation
- Discuss urgently with an experienced cardiologist/interventional team when the pattern is present with a compatible acute presentation, especially with ongoing symptoms or instability.
- Consider emergency coronary angiography/revascularization when the integrated clinical and ECG picture indicates ongoing acute coronary occlusion or very-high-risk ACS. Do not make the decision from the eponym alone.
- At angiography, assess the inferior-wall culprit territory while recognizing that concomitant critical lesions may be present. The ECG may help focus attention but cannot reliably identify the culprit vessel in every patient.
- Provide guideline-directed ACS care, including antithrombotic and secondary-prevention treatment as appropriate to the confirmed diagnosis, bleeding risk, anatomy and local protocol.
9. Common Interpretation Pitfalls
- Calling the tracing “NSTEMI” and stopping the ECG assessment because contiguous inferior ST elevation is absent.
- Failing to compare lead III with both II and aVF, thereby overlooking that the elevation is isolated.
- Missing subtle ST depression in V4–V6 or overlooking a positive terminal T-wave component.
- Comparing V1 and V2 inaccurately because of baseline selection, artefact or lead placement.
- Assuming that the pattern proves a specific culprit artery or guarantees acute total occlusion.
- Ignoring prior ECGs, previous infarction, serial changes and the patient's clinical stability.
- Delaying escalation while waiting for troponin results in a patient with ongoing ischaemia or haemodynamic compromise.
10. ECG Interpretation Example
The supplied PDF includes a second clinical example described as a 57-year-old woman with hypertension and chest pain, without previous heart disease reported in the source.
Interpretation task: Review the tracing and assess the three defining features in sequence. The supplied PDF does not provide a full set of measured ST amplitudes, biomarker results or angiographic findings for this case; these should not be inferred from the image.
Knowledge check: Which combination defines the classic Aslanger pattern?
11. ECG Pearls and Quick Reference
- Think of Aslanger pattern when ST elevation is isolated to lead III rather than present across the inferior leads.
- Always inspect V4–V6 for ST depression with a positive or terminally positive T wave.
- Compare the ST level in V1 directly with V2; V1 should be higher.
- The pattern is associated with inferior MI and concomitant critical disease in other coronary territories in the original description.
- It may signal an OMI despite failure to meet conventional contiguous-lead STEMI criteria.
- It is a high-risk clue, not a definitive diagnosis, culprit-vessel locator or treatment algorithm.
12. References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.